These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 1800016)

  • 61. 1 alpha-hydroxyvitamin D3 inhibits type II collagen-induced arthritis in rats.
    Tsuji M; Fujii K; Nakano T; Nishii Y
    FEBS Lett; 1994 Jan; 337(3):248-50. PubMed ID: 8293808
    [TBL] [Abstract][Full Text] [Related]  

  • 62. 1-alpha-hydroxyvitamin D3 in chronic renal failure. A potent analogue of the kidney hormone, 1,25-dihydroxycholecalciferol.
    Chan JC; Oldham SB; Holick MF; DeLuca HF
    JAMA; 1975 Oct; 234(1):47-52. PubMed ID: 1174223
    [TBL] [Abstract][Full Text] [Related]  

  • 63. 1 alpha-Hydroxyvitamin D3 in the treatment of primary myelofibrosis: in vitro effect of vitamin D3 metabolites on the bone marrow fibroblasts.
    Hyodo H; Kimura A; Nakata Y; Ohta H; Kuramoto A
    Int J Hematol; 1993 Apr; 57(2):131-7. PubMed ID: 8388271
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Another Step Forward in Iron Chelation Therapy.
    Angelucci E
    Acta Haematol; 2015; 134(4):231-2. PubMed ID: 26138742
    [No Abstract]   [Full Text] [Related]  

  • 65. Deferasirox Decreases Liver Iron Concentration in Iron-Overloaded Patients with Myelodysplastic Syndromes, Aplastic Anemia and Other Rare Anemias.
    Kohgo Y; Urabe A; Kilinç Y; Agaoglu L; Warzocha K; Miyamura K; Lim LC; Glaser S; Wang C; Wiktor-Jedrzejczak W
    Acta Haematol; 2015; 134(4):233-42. PubMed ID: 26138856
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Effect of 1 alpha-hydroxyvitamin D3 treatment on production of tumor necrosis factor-alpha by peripheral blood mononuclear cells and on serum concentrations of soluble tumor necrosis factor receptors in hemodialysis patients.
    Haran N; Gurwicz S; Gallati H; Shalita B; Bar-Khayim Y
    Nephron; 1994; 66(3):262-6. PubMed ID: 8190177
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Transformation from aplastic anemia to myelodysplastic syndromes--report of two cases and review of the literature].
    Hotta T; Yamao H; Kato T; Murate T; Utsumi M; Yamada H; Saito H
    Rinsho Ketsueki; 1986 Oct; 27(10):1891-8. PubMed ID: 3820613
    [No Abstract]   [Full Text] [Related]  

  • 68. Treatment of osteomalacia associated with primary biliary cirrhosis with oral 1-alpha-hydroxy vitamin D3.
    Compston JE; Crowe JP; Horton LW
    Br Med J; 1979 Aug; 2(6185):309. PubMed ID: 476441
    [No Abstract]   [Full Text] [Related]  

  • 69. Differentiating and antitumor activities of 1 alpha,25-dihydroxyvitamin D3 in vitro and 1 alpha-hydroxyvitamin D3 in vivo on human osteosarcoma.
    Tsuchiya H; Morishita H; Tomita K; Ueda Y; Tanaka M
    J Orthop Res; 1993 Jan; 11(1):122-30. PubMed ID: 8423514
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Vitamin K2 therapy for myelodysplastic syndrome].
    Abe Y; Muta K; Hirase N; Choi I; Matsushima T; Hara K; Taguchi F; Suematsu E; Shibata K; Uike N; Nishimura J; Nawata H
    Rinsho Ketsueki; 2002 Feb; 43(2):117-21. PubMed ID: 11925874
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Comparison of therapeutic usefulness of vitamin D3 analogs on osteoporosis caused by ovariectomy in rats.
    Izawa Y; Sagara K; Kadota T; Makita T
    Acta Vitaminol Enzymol; 1985; 7(3-4):173-81. PubMed ID: 3841463
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Randomized study comparing vitamin D3 and 1α-Hydroxyvitamin D3 in combination with pegylated interferon/ribavirin therapy for chronic hepatitis C.
    Omori-Mizuno Y; Nakayama N; Inao M; Funyu J; Asabe S; Tomita K; Nishikawa K; Hosoda Y; Tanaka M; Hashimoto Y; Yakabi K; Koshima Y; Mochida S
    J Gastroenterol Hepatol; 2015 Sep; 30(9):1384-90. PubMed ID: 25778685
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Short-term effects of 1-alpha-hydroxy-vitamin D3 in patients on corticosteroid treatment and in patients with senile osteoporosis.
    Lindgren U; Lindholm S; Sarby B
    Acta Med Scand; 1978; 204(1-2):89-92. PubMed ID: 685736
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Cyclosporine-Olanzapine Drug-Drug Interaction.
    Robles-Martínez M; Monge MF; Iglesias-González M
    Prim Care Companion CNS Disord; 2018 Apr; 20(2):. PubMed ID: 29701931
    [No Abstract]   [Full Text] [Related]  

  • 75. 23,25-Dihydroxyvitamin D3: a natural precursor in the biosynthesis of 25-hydroxyvitamin D3-26,23-lactone.
    Tanaka Y; DeLuca HF; Schnoes HK; Ikekawa N; Eguchi T
    Proc Natl Acad Sci U S A; 1981 Aug; 78(8):4805-8. PubMed ID: 6975475
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Malignant osteopetrosis treated with high doses of 1 alpha-hydroxyvitamin D3 and interferon gamma.
    Kubo T; Tanaka H; Ono H; Moriwake T; Kanzaki S; Seino Y
    J Pediatr; 1993 Aug; 123(2):264-8. PubMed ID: 8345424
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Synthesis, biologic activity, and protein binding characteristics of a new vitamin D analog, 22-hydroxyvitamin D3.
    Gill HS; Londowski JM; Corradino R; Kumar R
    J Steroid Biochem; 1987 Aug; 28(2):147-53. PubMed ID: 3041108
    [TBL] [Abstract][Full Text] [Related]  

  • 78. A case of hypophosphataemic vitamin D-resistant rickets treated with initial massive doses of 1 alpha-hydroxy-vitamin D3 alone.
    Muraki K; Nishi Y; Tsuda K; Yoshimitsu K; Usui T
    Acta Paediatr Scand; 1983 Sep; 72(5):763-8. PubMed ID: 6314737
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Successful treatment of genetically hypophosphatemic mice by 1 alpha-hydroxyvitamin D3 but not 1,25-dihydroxyvitamin D3.
    Beamer WG; Wilson MC; DeLuca HF
    Endocrinology; 1980 Jun; 106(6):1949-55. PubMed ID: 6892799
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Low serum vitamin D levels are associated with shorter survival after first-line azacitidine treatment in patients with myelodysplastic syndrome and secondary oligoblastic acute myeloid leukemia.
    Radujkovic A; Schnitzler P; Ho AD; Dreger P; Luft T
    Clin Nutr; 2017 Apr; 36(2):542-551. PubMed ID: 26899917
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.